Thus, they can suppress β-catenin levels by increasing nemo-like kinase (NLK) and adenomatous polyposis coli 2 (APC2) expressions, respectively, which eventually prohibit tumor progression in vivo. The gene discussed is NLK; the disease is neoplasm.